Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II)

Heart. 2004 Sep;90(9):995-8. doi: 10.1136/hrt.2003.028811.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Coronary Restenosis / economics
  • Coronary Restenosis / prevention & control*
  • Cost-Benefit Analysis
  • Drug Implants
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / economics
  • Length of Stay
  • Male
  • Middle Aged
  • Myocardial Infarction / etiology
  • Platelet Aggregation Inhibitors / therapeutic use
  • Sirolimus / administration & dosage*
  • Sirolimus / economics
  • Stents* / economics
  • Survival Analysis
  • Treatment Outcome

Substances

  • Drug Implants
  • Immunosuppressive Agents
  • Platelet Aggregation Inhibitors
  • Sirolimus